Mepolizumab in severe uncontrolled CRSwNP: a real-life multicentre study in Northeast Italy
Mepolizumab is effective in improving nasal obstruction and the sense of smell in patients with severe uncontrolled CRSwNP, based on both patient- and physician derived outcome measures.
Authors
- Fabrizio Corlianò (ORCID: https://orcid.org/0000-0001-6696-3959)
- Sonny Zampollo
- Tommaso Saccardo (ORCID: https://orcid.org/0000-0002-8349-9569)
- Stefano Rossi (ORCID: https://orcid.org/0000-0001-7214-4634)
- Piero Nicolai (ORCID: https://orcid.org/0000-0003-0443-3519)
- Bruna Scarpa (ORCID: https://orcid.org/0000-0002-2838-9201)
- Giancarlo Ottaviano (ORCID: https://orcid.org/0000-0003-2433-4761)
- Gabriele Roccuzzo (ORCID: https://orcid.org/0000-0001-7126-5506)
- Simone Santini (ORCID: https://orcid.org/0000-0002-1869-5301)
- Maria Baldovin (ORCID: https://orcid.org/0000-0002-1557-9321)
- Michele Schiappoli (ORCID: https://orcid.org/0000-0002-4718-5984)
- Erika Rigoni
- Sara Munari
- Leonardo Calvanese (ORCID: https://orcid.org/0000-0002-5628-0190)
- Roberto Marangoni (ORCID: https://orcid.org/0000-0002-6603-6984)
- L G Locatello
- A De Massimi
- L. Lora
- L Pierotello
- I Barbarino
- K Pacaj
Institutions
- University of Padua (IT)
- AULSS 2 Marca Trevigiana (IT)
- Ospedale San Bassiano (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
Publication Details
- Journal
- Rhinology Journal
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4193/rhin24.420
- Citations
- 3
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 5.54